Platelet count and parasite density: independent variable in Plasmodium vivax malaria.

نویسندگان

  • Dhanpat Kumar Kochar
  • Gajanand Singh Tanwar
  • Renu Agrawal
  • Shilpi Kochar
  • Gayatri Tanwar
  • Swati Kochar Falodia
  • Abhishek Kochar
  • Sheetal Middha
  • Sanjay Kumar Kochar
چکیده

The occurrence of thrombocytopenia in Plasmodium vivax malaria is well-documented. In spite of being a common observation, its prognostic implications in context with parasite density has not been evaluated. In view of the paucity of data, we attempted to study the correlation of platelet count with parasite density in P. vivax monoinfection. This prospective study was carried out on patients attending outpatient clinic from June 2011 to December 2011. The study was conducted on patients coming to out patient department at the time of first consultation for fever in which diagnosis of P. vivax monoinfection was made by peripheral blood smear (PBS) and rapid diagnostic test (RDT). Patients having severe malarial manifestations were enrolled in another observational study (under process) and confirmation of malarial species in them was made by PCR analysis. Due to inclusion of large number of patients in the present study, we used an ‘OptiMAL® Rapid Malaria Dipstick Test’ to rule out concomitant low density P. falciparum mixed infection. This test detects the presence of Plasmodium lactate dehydrogenase (pLDH); an enzyme produced both by the sexual and asexual forms of the parasite. The presence of pLDH is revealed using monoclonal antibodies directed against isoforms of the enzyme. This test detects parasitemia levels of 100–200 parasites per μl of blood (corresponding to a parasitemia of 0.002–0.004%). Another point against the presence of associated P. falciparum infection is that such a low parasitemia of P. falciparum so as to be undetectable both by the dipstick test and standard microscopy, is highly unlikely to cause such profound thrombocytopenia. The possibilities of other concurrent similar illness causing thrombocytopenia were ruled out by appropriate and stringent laboratory investigations. Details are given in our previous study1. Platelet count was done by fully automated counter and the results were derived from directly measured platelet pulses, multiplied by a calibration constant and expressed in 1000 thrombocytes/l of whole blood. A written informed consent was mandatory and those who refused to give the written consent or had other concurrent illness were not included in the study. This study includes 599 patients of P. vivax monoinfection, but parasite density was done only in 546 patients fulfilling the eligibility criteria. The age distribution range included in the study was 1–60 yr and sex ratio was 2.33 (male : female = 382 : 164). The mean ± SD platelet count and mean ± SD parasite density were 90199.6 ± 57414.9 and 6733.4 ± 9523.8, respectively. Thrombocytopenia (<150,000/mm3) was present in 85.71% (468/546) patients with a mean platelet count of 72715.8 ± 38625.4. Statistical analysis done by correlation coefficient did not show any association between platelet count and parasite load [correlation coefficient (R2) = 0.000] (Fig. 1). All these patients were treated as per WHO guidelines.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Genetic mutations in 57 and 58 codons gene of Plasmodium vivax dihydrofolate reductase

Introduction: The use of Sulfadoxine and pyrimethamine (SP) for treatment of vivax malaria is not common in most of malarious areas because of sensivity of this parasite to chloroquine. But, Plasmodium vivax isolates are exposed to SP because of mixed infection with P.falciparum and this subject has lead to emergence of mutations in P.vdhfr gene. As Plasmodium vivax is the most prevalent specie...

متن کامل

Clinical Pharmacology of the Antimalarial Chloroquine in Children and Their Mothers

Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium knowlesi are the parasites that infect humans. Plasmodium falciparum and Plasmodium vivax cause most of the malarial infections worldwide. Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium knowlesi are susceptible to chloroquine. Chloroquine was the world's most widely used antim...

متن کامل

Response of plasmodium vivax malaria induced thrombocytopenia to antimalarial treatment.

BACKGROUND Thrombocytopenia is often seen in the patients of malaria infected with Plasmodium vivax. We studied patients admitted in hospital having coexisting thrombocytopenia and malaria, and recorded the response to anti-malarial therapy. METHODS In this cross-sectional descriptive study, a total of 120 patients admitted in medical ward with Plasmodium vivax malaria and co-existing thrombo...

متن کامل

Effect of Malaria Parasite Infection on Platelet Parameters (Platelets count, mean platelets volume and platelets distribution width) among Malaria Patients in Khartoum State

Malaria is one of the endemic diseases in tropical and subtropical areas. In Sudan, malaria is one of the common diseases and can sometimes be fatal. This prospective case control study was carried out in Khartoum State –Sudan to study the effect of malaria parasite infection on platelets count, mean platelet volume (MPV) and platelets distribution width (PDW) among malaria patients. A total of...

متن کامل

Clinical Pharmacology of the Antimalarial Artemisinin-Based Combination and other Artemisinins in Children

In 2010, there were estimated 219 million cases of malaria resulting in 666,000 deaths and two-thirds were children. Children are more vulnerable than adults to malaria parasites. In sub-Saharan African countries, maternal malaria is associated with up to 200,000 estimated infant deaths yearly. Malaria is caused by five Plasmodium parasites namely: Plasmodium falciparum, Plasmodium vivax, Plasm...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Journal of vector borne diseases

دوره 49 3  شماره 

صفحات  -

تاریخ انتشار 2012